Deferred Tax Assets, Valuation Allowance of Xenetic Biosciences, Inc. from 31 Dec 2012 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Xenetic Biosciences, Inc. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2012 to 31 Dec 2025.
  • Xenetic Biosciences, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2025 was $39,791,852, a 3.3% decline year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

Xenetic Biosciences, Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $39,791,852 -$1,337,685 -3.3% 31 Dec 2025 10-K 12 Mar 2026 2025 FY
Q3 2025 $41,700,000 +$1,100,000 +2.7% 30 Sep 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 $41,600,000 +$1,200,000 +3% 30 Jun 2025 10-Q 12 Aug 2025 2025 Q2
Q1 2025 $41,400,000 +$1,300,000 +3.2% 31 Mar 2025 10-Q 13 May 2025 2025 Q1
Q4 2024 $41,129,537 +$1,422,425 +3.6% 31 Dec 2024 10-K 12 Mar 2026 2025 FY
Q3 2024 $40,600,000 +$1,400,000 +3.6% 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 $40,400,000 +$1,400,000 +3.6% 30 Jun 2024 10-Q 13 Aug 2024 2024 Q2
Q1 2024 $40,100,000 +$1,400,000 +3.6% 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 $39,707,112 +$1,138,016 +3% 31 Dec 2023 10-K 18 Mar 2025 2024 FY
Q3 2023 $39,200,000 +$6,400,000 +20% 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 $39,000,000 +$6,400,000 +20% 30 Jun 2023 10-Q 10 Aug 2023 2023 Q2
Q1 2023 $38,700,000 +$6,900,000 +22% 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 $38,569,096 +$7,193,509 +23% 31 Dec 2022 10-K 21 Mar 2024 2023 FY
Q3 2022 $32,800,000 +$2,300,000 +7.5% 30 Sep 2022 10-Q 09 Nov 2022 2022 Q3
Q2 2022 $32,600,000 +$2,400,000 +7.9% 30 Jun 2022 10-Q 11 Aug 2022 2022 Q2
Q1 2022 $31,800,000 +$1,900,000 +6.4% 31 Mar 2022 10-Q 12 May 2022 2022 Q1
Q4 2021 $31,375,587 +$1,731,346 +5.8% 31 Dec 2021 10-K 22 Mar 2023 2022 FY
Q3 2021 $30,500,000 +$4,000,000 +15% 30 Sep 2021 10-Q 12 Nov 2021 2021 Q3
Q2 2021 $30,200,000 +$3,900,000 +15% 30 Jun 2021 10-Q 12 Aug 2021 2021 Q2
Q1 2021 $29,900,000 +$3,800,000 +15% 31 Mar 2021 10-Q 11 May 2021 2021 Q1
Q4 2020 $29,644,241 +$3,771,394 +15% 31 Dec 2020 10-K 22 Mar 2022 2021 FY
Q3 2020 $26,500,000 +$300,000 +1.1% 30 Sep 2020 10-Q 12 Nov 2020 2020 Q3
Q2 2020 $26,300,000 +$2,200,000 +9.1% 30 Jun 2020 10-Q 12 Aug 2020 2020 Q2
Q1 2020 $26,100,000 +$2,300,000 +9.7% 31 Mar 2020 10-Q 14 May 2020 2020 Q1
Q4 2019 $25,872,847 +$2,387,949 +10% 31 Dec 2019 10-K 16 Mar 2021 2020 FY
Q3 2019 $26,200,000 +$2,200,000 +9.2% 30 Sep 2019 10-Q 14 Nov 2019 2019 Q3
Q2 2019 $24,100,000 +$500,000 +2.1% 30 Jun 2019 10-Q 14 Aug 2019 2019 Q2
Q1 2019 $23,800,000 +$600,000 +2.6% 31 Mar 2019 10-Q 13 May 2019 2019 Q1
Q4 2018 $23,484,898 +$719,959 +3.2% 31 Dec 2018 10-K 26 Mar 2020 2019 FY
Q3 2018 $24,000,000 $0 0% 30 Sep 2018 10-Q 09 Nov 2018 2018 Q3
Q2 2018 $23,600,000 +$400,000 +1.7% 30 Jun 2018 10-Q 10 Aug 2018 2018 Q2
Q1 2018 $23,200,000 -$1,200,000 -4.9% 31 Mar 2018 10-Q 15 May 2018 2018 Q1
Q4 2017 $22,764,939 +$1,261,157 +5.9% 31 Dec 2017 10-K 29 Mar 2019 2018 FY
Q3 2017 $24,000,000 +$7,500,000 +45% 30 Sep 2017 10-Q 14 Nov 2017 2017 Q3
Q2 2017 $23,200,000 +$6,700,000 +41% 30 Jun 2017 10-Q 14 Aug 2017 2017 Q2
Q1 2017 $24,400,000 +$7,900,000 +48% 31 Mar 2017 10-Q 15 May 2017 2017 Q1
Q4 2016 $21,503,782 +$6,179,344 +40% 31 Dec 2016 10-K 30 Mar 2018 2017 FY
Q3 2016 $16,500,000 -$700,000 -4.1% 30 Sep 2016 10-Q 14 Nov 2016 2016 Q3
Q2 2016 $16,500,000 +$1,400,000 +9.3% 30 Jun 2016 10-Q 15 Aug 2016 2016 Q2
Q1 2016 $16,500,000 +$1,900,000 +13% 31 Mar 2016 10-Q 16 May 2016 2016 Q1
Q4 2015 $15,324,438 +$1,551,029 +11% 31 Dec 2015 10-K 31 Mar 2017 2016 FY
Q3 2015 $17,200,000 +$3,700,000 +27% 30 Sep 2015 10-Q 16 Nov 2015 2015 Q3
Q2 2015 $15,100,000 +$3,100,000 +26% 30 Jun 2015 10-Q 19 Aug 2015 2015 Q2
Q1 2015 $14,600,000 +$4,600,000 +46% 31 Mar 2015 10-Q 20 May 2015 2015 Q1
Q4 2014 $13,773,409 +$4,252,149 +45% 31 Dec 2014 10-K 30 Mar 2016 2015 FY
Q3 2014 $13,500,000 30 Sep 2014 10-Q 14 Nov 2014 2014 Q3
Q2 2014 $12,000,000 30 Jun 2014 10-Q 14 Aug 2014 2014 Q2
Q1 2014 $10,000,000 31 Mar 2014 10-Q 20 May 2014 2014 Q1
Q4 2013 $9,521,260 +$373,772 +4.1% 31 Dec 2013 10-K 20 Jul 2015 2013 FY
Q4 2012 $9,147,488 31 Dec 2012 10-K 20 Jul 2015 2013 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.